Gaudium IVF IPO Allotment Status Today: How to Check, GMP & Listing

The Gaudium IVF and Women Health IPO has reached a key milestone as investors eagerly await the allotment results, which are likely to be released today on 25 February 2026. After closing its subscription on 24 February 2026, the next important phase in the IPO journey is the allotment process. Once confirmed, successful bidders will have their shares credited to their Demat accounts ahead of the official listing on 27 February 2026.

Investors can check their allotment status online through several convenient methods. One of the simplest ways is by visiting the registrar’s official portal, where applicants can enter their PAN (Permanent Account Number) or application number to view the outcome. Another method involves checking the BSE or NSE website, where allotment status is also updated once it is finalised. These online tools are particularly useful for retail investors who applied through broker platforms or UPI gateways. Once the allotment status is live, the portal will generally update with status indicators such as “Allotted”, “Rejected”, or “Partially Allotted”.

Market participants have also been tracking the grey market premium (GMP) as an informal but closely watched indicator of expected listing performance. Ahead of allotment day, the GMP for Gaudium IVF IPO remained robust, reflecting positive sentiment among unofficial market traders. With the IPO priced in the band of ₹75 to ₹79 per share, many grey market observers were reporting premium values that indicated expectations of healthy listing gains on debut. Although GMP does not guarantee actual market performance, it provides a snapshot of perceived demand and pricing expectations among traders and investors.

The IPO itself generated strong interest from the market during the subscription window that ran from 20 February to 24 February 2026. Retail investors showed enthusiastic participation, contributing significantly towards the overall subscription numbers. Non-institutional and institutional bidders also took part, driven by confidence in the company’s position within the fertility and women’s healthcare segment. This blend of investor categories helped make the IPO one of the more closely watched offerings in the early 2026 primary market calendar.

Gaudium IVF and Women Health operates across a network of locations in India, providing advanced fertility treatments including In Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI) and related reproductive health services. Its business model focuses on specialised care delivered through hubs and spokes, enabling a wider geographical spread and accessibility. This operational structure has appealed to investors who view the healthcare space as a long-term growth opportunity, especially in areas such as fertility services where demand has been rising steadily.

Once the allotment is finalised, shares that have been allotted will be credited to successful applicants’ Demat accounts by 26 February 2026. This step is critical because it allows investors to have their holdings ready in time for the public trading debut on 27 February 2026, when the IPO will list on both the NSE and BSE. The listing day is anticipated with excitement, especially given the healthy grey market premium and strong subscription metrics observed during the issue period.

For those investors who are allocated shares, the upcoming listing date is an important milestone to track potential gains, while long-term holders will likely evaluate the company’s fundamentals and future growth trajectory. For applicants who were not allotted shares, the refund process is expected to begin soon after the allotment announcement. Refunds are generally credited back to the bank accounts used during the IPO application, and investors can expect updates from their broker or registrar once the process begins.

In summary, the Gaudium IVF IPO allotment is a key event for investors today on 25 February 2026. With robust market participation, positive grey market indicators and a scheduled listing on 27 February 2026, this IPO marks an important addition to the healthcare segment’s presence on Indian exchanges. Investors should check their allotment status using online portals as soon as it is published and prepare for the upcoming listing based on the results.